Nov 5, 2025 04:00PM
Nov 5, 2025 04:00PM
Aug 7, 2025 04:00PM
May 6, 2025 04:01PM
Apr 21, 2025 04:05PM
Mar 18, 2025 08:03AM
Mar 18, 2025 08:00AM Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun
Feb 20, 2025 04:01PM
Feb 11, 2025 03:58AM
Jan 13, 2025 09:10AM
Jan 13, 2025 09:00AM
Nov 7, 2024 04:02PM
Aug 6, 2024 04:01PM
Jun 27, 2024 04:09PM Dynavax (DVAX) Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
Jun 27, 2024 04:09PM
May 14, 2024 03:16PM
May 14, 2024 08:33AM
May 14, 2024 08:30AM
May 8, 2024 04:01PM
Feb 22, 2024 04:01PM
Jan 8, 2024 09:04AM Dynavax (DVAX) Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
Jan 8, 2024 09:00AM
Nov 2, 2023 04:01PM
Aug 3, 2023 04:05PM
May 2, 2023 04:05PM
Mar 2, 2023 01:00AM
Dec 30, 2022 12:30PM
Sep 26, 2022 01:00AM Valneva Provides Further Update on its COVID-19 Activities
Sep 16, 2022 04:30PM
Sep 6, 2022 01:00AM
Aug 29, 2022 01:00AM
Aug 23, 2022 11:45AM
Aug 1, 2022 11:45AM
Jul 20, 2022 12:00PM
Jun 24, 2022 12:00PM Valneva (VALN) Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
Jun 24, 2022 12:00PM
Jun 23, 2022 09:16AM
Jun 15, 2022 11:45AM
Jun 10, 2022 12:30PM
Jun 10, 2022 12:30PM
May 19, 2022 05:41AM
May 19, 2022 01:00AM EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate
May 16, 2022 05:17AM
May 16, 2022 01:15AM
May 16, 2022 01:15AM
May 16, 2022 01:15AM
May 16, 2022 01:15AM
May 16, 2022 01:15AM
May 16, 2022 01:15AM Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement
May 16, 2022 01:15AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All